Form 4: Anterix Director Sells 7,000 Shares Under 10b5-1 Plan

Anterix Inc. Director and 10% owner Mahvash Yazdi reported the sale of 7,000 common shares at $80 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Mahvash Yazdi, a Director and 10% owner of Anterix Inc. (ATEX), reported the sale of 7,000 shares of Common Stock.
• The transaction occurred on June 16, 2026, with a sale price of $80 per share.
• The sale was conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following the transaction, Ms. Yazdi directly owns 19,407 shares.
• Indirect beneficial ownership includes 250 shares through the Yazdi Family Trust UA Oct 03, 1988, and 750 shares through a 401(k) plan, totaling 20,407 shares beneficially owned.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative development due to the insider sale by a significant shareholder, though the pre-arranged 10b5-1 plan mitigates concerns of opportunistic selling.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information.

Negatives

• A Director and 10% owner sold 7,000 shares of common stock.
• The sale price was $80 per share.

Risks

• Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence in the company's future prospects by an informed insider.

Future Outlook

No explicit future outlook or guidance is provided in this Form 4 filing, which is a report on a past insider transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly by significant shareholders like a 10% owner and director, are closely watched by the market. While a 10b5-1 plan mitigates the immediate negative signal, it still represents a reduction in insider holdings, which can be viewed differently than open market purchases.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal regarding the company's future prospects, potentially leading to negative sentiment.

Key Dates

Recommendation

The sale by a director and 10% owner, while notable, was executed under a pre-arranged 10b5-1 plan, which suggests it was not based on new, adverse material information. This transaction alone does not fundamentally alter the investment thesis for Anterix Inc., but it warrants a "hold" as investors should monitor future insider activity and company performance.

Keywords

Anterix Inc., ATEX, Form 4, Insider Sale, Mahvash Yazdi, Director, 10b5-1 Plan, Stock Transaction, Beneficial Ownership